Global Recombinant Proteins Market Report 2022: Increased R&D Spending by Pharmaceutical Companies Boosting Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Recombinant Proteins Market Share, Size, Trends, Industry Analysis Report, By Product & Services, By Application, By End-Use, By Region, Segment Forecast, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.

The global recombinant proteins market size is expected to reach USD 5.04 billion by 2030, according to a new study.

A significant increase in government funding, increased R&D spending by pharmaceutical companies, and increasing non-communicable and chronic illnesses is expected to drive demand. Furthermore, the availability of a diverse range of innovations from human and animal sources and the rising demand for biological products is expected to drive industry growth.

In addition, other factors that are expected to complement growth opportunities include growing interest in personalized medicine and protein therapeutics. Several countries in Asia Pacific, including India, China, Japan, and South Korea, are likely to influence industry growth positively. However, decreasing the cost of the product may have some limitations, likely restraining industry growth.

The COVID-19 pandemic benefited the industry due very high number of coronavirus infections. It has allowed several research units to develop various combinations of recombination protein subunits, leading to a huge rise in demand for the product.

Recombinant Proteins Market Report Highlights

• The demand for the therapeutics segment is expected to drive the revenue growth as demand for effective and convenient treatments is expected to witness growth over the forecast period
• The enzymes segment accounted for the highest revenue share in 2021 and is expected to continue its dominance owing to the usage of enzymes in many research domains such as wound repairs, oncology, and other diseases
• The pharmaceutical & biotech companies segment is expected to spearhead revenue growth to forecast and diagnose drug research more frequently
• Asia Pacific is expected to witness substantial growth over the forecast period on account of several non-curable illnesses that are increasing across developing economies like India and China with increasing R&D initiatives
• Major players operating in the industry include Abcam plc, Abnova Corp, Aviva systems biology, Bio-Techne corporation, Bio-Rad laboratories, Elpiscience, Elevian inc, Eli Lilly and co, Enzo life sciences, Inc, Gigagen inc, Genscript, Janssen-Cilag pty ltd, Merck KGaA, Proteinrech Group, Inc, R&D System, Inc, Raybiotech Life Inc., Stemcell Technologies Inc, Sino Biological Inc, Thermo Fisher Scientific, and U Protein Express

The publisher has segmented the recombinant proteins market report based on product & services, application, end-use, and region:

Recombinant Proteins, Product & Services Outlook (Revenue - USD Billion, 2018 - 2030)

• Product
• Cytokines & Growth Factors
• Interferons (IFNs)
• Interleukins (ILs)
• Others
• Antibodies
• Immune Checkpoint Proteins
• Virus Antigens
• Enzymes
• Kinases
• Metabolic Enzymes
• Others
• Recombinant Regulatory Proteins
• Hormones
• Others
• Production Services

Recombinant Proteins, Application Outlook (Revenue - USD Billion, 2018 - 2030)

• Drug Discovery & Development
• Therapeutics
• Biologics
• Vaccines
• Cell & Gene Therapies
• Others
• Research
• Others

Recombinant Proteins, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Diagnostic Laboratories
• Others

Recombinant Proteins, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

• North America
• U.S
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Latin America
• Argentina
• Brazil
• Mexico
• Middle East & Africa
• UAE
• Saudi Arabia
• Israel
• South Africa

Key Topics Covered:

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Recombinant Proteins Market Insights

5. Global Recombinant Proteins Market, by Product & Services

6. Global Recombinant Proteins Market, by Application

7. Global Recombinant Proteins Market, by End-Use

8. Global Recombinant Proteins Market, by Geography

9. Competitive Landscape

10. Company Profiles

Companies Mentioned

• Abcam plc
• Abnova Corp
• Aviva systems biology
• Bio-Techne corporation
• Bio-Rad laboratories
• Elpiscience
• Elevian inc
• Eli lilly and co
• Enzo life sciences Inc
• Gigagen inc
• Genscript
• Janssen-Cilag pty ltd
• Merck KGaA
• Proteinrech Group Inc
• R&D System Inc
• Raybiotech Life Inc
• Stemcell Technologies Inc
• Sino Biological Inc
• Thermo Fisher Scientific
• U Protein Express

For more information about this report visit https://www.researchandmarkets.com/r/bzte3f

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900